Generalizability of clinical trials for cannabis dependence to community samples. - Wikidata - wikimedia - TriplyDB

Generalizability of clinical trials for cannabis dependence to community samples.

Generalizability of clinical trials for cannabis dependence to community samples.

http://www.wikidata.org/entity/Q35582292

about

Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder Visual aggregate analysis of eligibility features of clinical trials Toward National Estimates of Effectiveness of Treatment for Substance Use Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Generalizability of pharmacological and psychotherapy clinical trial results for borderline personality disorder to community samples The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings Assessing the Sensitivity of Treatment Effect Estimates to Differential Follow-Up Rates: Implications for Translational Research Alcohol Dependence, Co-occurring Conditions and Attributable Burden.Predicting Participation in Psychiatric Randomized Controlled Trials: Insights From the STEP-BD Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.Representativeness of the participants in the smoking Cessation in Pregnancy Incentives Trial (CPIT): a cross-sectional study.Representativeness of obstetric patients who participate in perinatal depression research: findings from the Women's Mental Health and Infants Program (WMHIP) integrated dataset.Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis.Pragmatic trial of a Study Navigator Model (NAU) vs. Ambassador Model (N+) to increase enrollment to health research among community members who use illicit drugs.Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.Generalizability of clinical trial results for generalized anxiety disorder to community samples.A response to Tucker (2012).Grappling with the generalizability crisis in addiction treatment research.Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta-analytic studies.Implications of enrolment eligibility criteria in alcohol treatment outcome research: generalisability and potential bias in 1- and 6-year outcomes.Who is smoking pot for fun and who is not? An overview of instruments to screen for cannabis-related problems in general population surveys

P2860

Q21559698-0AC04AE4-F73E-44C2-A123-253C0FC3E784 Q26778626-198323FE-F465-4C8D-97A4-FC188DBD80F9 Q27025821-185B6514-6C23-483F-A980-B3EF7FE1FD04 Q28648496-ECE4478C-A989-4FCD-90FC-A8A9DE43E7EE Q33852341-7AAD3561-357B-4168-81B7-303BDF4D2F41 Q35113687-8B87D718-EBE2-48B3-AAD7-7F827D829B24 Q35214927-30EE1CF5-3224-4859-993C-9BED00E3FDF9 Q36200016-397C7D06-B394-4C8A-8CFA-E62BBA6ADC47 Q36206381-E2DF3BF7-C55F-4E8B-B3B0-DD5BC3B6420F Q36585470-DE3A12F7-B49E-4113-BBF5-CEE398A1E2D8 Q36955805-A5DEB2F8-DA86-44AE-B15A-8D0F7418FFB3 Q36984080-54BF4DB0-2F62-4DA1-AF35-9B513764292D Q37212076-E4741111-6372-4194-A6F4-98D69155D6F8 Q38394175-57360156-2C87-478B-BBE6-78365C4AD4C8 Q38782542-DE30C009-21A0-44D1-9133-24E2A733B15E Q38871274-59F60D18-57CF-4359-AD64-C183E322CE6D Q40238042-106A97F6-69FD-432F-920F-A020D45A3A2D Q40338637-A022B928-AB62-45B7-9DA5-FAF5F138A500 Q44740214-7628961C-5F75-43D5-94EE-887555BED7E0 Q45052822-579E420B-40B7-42C4-B52C-7B05474CA150 Q48058198-9E2A0E14-5E71-47F4-AE3C-2B5894A7C635 Q49719710-B00F0713-ABCE-42AB-B51D-809F30CF2118 Q51780419-6E2341D9-6089-4D43-8FD9-D14CC510E78E Q58303788-D51B332B-A189-4C1C-9F28-DB4DC5C26E9E

P2860

Generalizability of clinical trials for cannabis dependence to community samples.

http://www.wikidata.org/entity/Q35582292

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Generalizability of clinical trials for cannabis dependence to community samples.

@ast

Generalizability of clinical trials for cannabis dependence to community samples.

@en

type

label

Generalizability of clinical trials for cannabis dependence to community samples.

@ast

Generalizability of clinical trials for cannabis dependence to community samples.

@en

prefLabel

Generalizability of clinical trials for cannabis dependence to community samples.

@ast

Generalizability of clinical trials for cannabis dependence to community samples.

@en

P1433

Q35582292-DB36DD9F-2D01-47C7-91C4-A81BD92EE065

P1476

Q35582292-8D5FE290-84ED-48A7-9D8F-CE25FF6E9A51

P2093

Q35582292-16FEAF76-5B56-4371-BC3B-761D2BE48C91

Q35582292-1A50A42E-623B-4ED4-88AD-B42B53E21414

Q35582292-1C049C9E-60CC-4F1F-A2B0-CAC757150214

Q35582292-A18B4E98-B2FE-48AE-BD21-EC33E3AEFAF7

Q35582292-BEA2EEC1-1957-4DC0-AD1D-8AF000BE8E67

Q35582292-C98EAD14-FC40-4632-B071-CA3128285D83

P2860

Q35582292-088D18D9-72AB-4FC1-926D-78BDD203CF48

Q35582292-1541C4FB-5D91-461A-B07E-C30D1F821909

Q35582292-16D512D2-B531-4594-BB99-30DABEC1DFC4

Q35582292-1A2BD26A-1A50-4F54-95C5-0E150CF7C86B

Q35582292-1C9F06E3-786F-4AB2-87D3-B765D568880B

Q35582292-1F22BBF4-3876-4EB7-8657-50195B4A3C0E

Q35582292-24DB6061-3D34-45FD-89A3-576831CBCD11

Q35582292-2B2B9D37-D562-4785-BBA3-38D7ED4D0DA0

Q35582292-2FCD742A-5AA4-476A-BBC5-A69DE0A2FFAB

Q35582292-31A1BED7-F918-4038-8670-F4DE8A790041

P304

Q35582292-61C1F837-A9C0-49F0-A65C-D38F651BD154

P31

Q35582292-92E7C633-506E-4BDC-8791-03FF9A1B2D81

P356

Q35582292-3CE723E1-4BD1-4D2E-A347-BC7088A3F906

P433

Q35582292-DDD134C1-A14E-44E5-B0DB-00C69FFC421D

P478

Q35582292-0D7207F6-7F40-4153-A96A-33A1733A7E06

P50

Q35582292-2A429576-C4B9-47E6-8DB8-7FA82D20FC7A

Q35582292-8CAD48A8-5C96-4FC3-96C1-EA59EE53A446

Q35582292-A8202C28-21A5-4269-8364-EB42C633E8A8

P577

Q35582292-DF882D0E-2ACE-4DA8-861D-6621437200A3

P5875

Q35582292-AF574E87-1DC3-4AF1-9E72-967CAB0BDE00

P698

Q35582292-494279DC-0938-4C53-9A0A-7607BD08AB0B

P932

Q35582292-C081EB36-0AF9-4678-8CC6-F83912EEC3CA

P356

J.DRUGALCDEP.2010.04.009

P1433

Drug and Alcohol Dependence

P1476

Generalizability of clinical trials for cannabis dependence to community samples.

@en

P2093

Edward V Nunes

http://www.w3.org/2001/XMLSchema#string

Ivan Montoya

http://www.w3.org/2001/XMLSchema#string

Mark Olfson

http://www.w3.org/2001/XMLSchema#string

Mayumi Okuda

http://www.w3.org/2001/XMLSchema#string

Shang-Min Liu

http://www.w3.org/2001/XMLSchema#string

Sharaf S Khan

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabis and schizophrenia

Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes

'Research' versus 'real-world' patients: representativeness of participants in clinical trials of treatments for cocaine dependence

Continuous, categorical, and time to event cocaine use outcome variables: degree of intercorrelation and sensitivity to treatment group differences.

A reevaluation of the exclusion criteria used in antidepressant efficacy trials.

Alcohol dependence and use of treatment services among women in the community.

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults.

Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.

P304

177-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2010.04.009

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Bridget F Grant

Deborah S Hasin

P577

2010-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44663303

http://www.w3.org/2001/XMLSchema#string

P698

20537813

http://www.w3.org/2001/XMLSchema#string

P932

3227418

http://www.w3.org/2001/XMLSchema#string